Combination of Genetics and Nanotechnology for Down Syndrome Modification: A Potential Hypothesis and Review of the Literature
Authors:
- Lireza TafazoliLTLireza Tafazoli
- Mohammad Reza AbbaszadeganMAMohammad Reza Abbaszadegan
Open Access
- 15 May 2019
- journal article
- review article
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 48 (3) , 371-378
Abstract
Down syndrome (DS) is one of the most prevalent genetic disorders in humans. The use of new approaches in genetic engineering and nanotechnology methods in combination with natural cellular phenomenon can modify the disease in affected people. We consider two CRISPR/Cas9 systems to cut a specific region from short arm of the chromosome 21 (Chr21) and replace it with a novel designed DNA construct, containing the essential genes in chromatin remodeling for inactivating of an extra Chr21. This requires mimicking of the natural cellular pattern for inactivation of the extra X chromosome in females. By means of controlled dosage of an appropriate Nano-carrier (a surface engineered Poly D, L-lactide-co-glycolide (PLGA) for integrating the relevant construct in Trisomy21 brain cell culture media and then in DS mouse model, we would be able to evaluate the modification and the reduction of the active extra Chr21 and in turn reduce substantial adverse effects of the disease, like intellectual disabilities. The hypothesis and study seek new insights in Down syndrome modification.Keywords
This publication has 50 references indexed in Scilit:
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Chronic Treatment with a Promnesiant GABA-A -Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse ModelAdvances in Pharmacological Sciences, 2011
- A cross-species comparison of escape from X inactivation in Eutheria: implications for evolution of X chromosome inactivationChromosoma, 2011
- Genes that escape from X inactivationHuman Genetics, 2011
- Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s diseaseJournal of Neurochemistry, 2011
- Global survey of escape from X inactivation by RNA-sequencing in mouseGenome Research, 2010
- Many X-linked microRNAs escape meiotic sex chromosome inactivationNature Genetics, 2009
- Identification of dysregulated genes in lymphocytes from children with Down syndromeGenome, 2008